Raul H. Oyola, MD came to the United States in July 1992 from Colombia to continue his studies in medicine. Upon completion of his Fellowship at the University of Tennessee in Memphis in 2001, Dr. Oyola joined Northwest Georgia Oncology Centers, P.C. (NGOC) and served at its Austell Cancer Center for a decade before moving his practice to Marietta in 2011.
As a Principal Investigator of NGOC’s William S. Gibbons Cancer Research Institute, Dr. Oyola leads NGOC’s participation in national cancer research and clinical trials. With a special interest in solid tumors, he is dedicated to finding a cancer cure and providing his patients with the most advanced cancer treatment available in Georgia.
Dr. Oyola is the past chairman WellStar Cancer Committee and WellStar Cobb Hospital Credentials Committee and served on the WellStar Oncology Cabinet.
“It’s important to offer cutting-edge clinical trials at NGOC since the majority of cancer patients are treated in a community setting. At NGOC, patients have access to experimental drugs and the latest research treatment modalities. These innovative therapies can only be offered by a community practice like NGOC if there is great motivation, commitment, interest, and dedication from the treating physicians.”
Dr. Oyola delivers patient-centered cancer care at NGOC’s Marietta Cancer Center.
Personal Data | Birthplace: Cordoba, Colombia U.S. citizen |
Medical Education | M.D., July 1990 Metropolitan University Barranquilla, Colombia |
Postdoctoral Training | INTERNSHIP AND RESIDENCY Internal Medicine St. John’s Episcopal Hospital State University of New York Far Rockaway, NY June 1995 – June 1998 FELLOWSHIP Medical Oncology and Hematology University of Tennessee Memphis, TN July 1998 – June 2001 |
Board Certification | American Board of Internal Medicine, Internal Medicine, 1998 American Board of Internal Medicine, Medical Oncology, 2001 American Board of Internal Medicine, Hematology, 2002 |
Medical Licensure | State of Georgia, 2001 (Active) |
Professional Societies | American Society of Clinical Oncology, 1998 - Present American Society of Hematology, 1998 - Present Cobb County Medical Society, 2001 - Present Medical Association of Georgia, 2001 - Present American College of Physicians, 1996 - 2000 Georgia Association of Clinical Oncology, 2003 - 2010 |
Honors | Co-Principal Investigator, William S. Gibbons Cancer Research Institute Associate Principal Investigator, Atlanta Regional CCOP, 2001- 2010 Scholarship for Academic Performance, 1989 MD with Honors, 1990 Certificate of Merit, Colombian Medical Society, 1991 |
Leadership Positions | Chairman of the Cancer Committee, WellStar Cancer Program, July 2006 - July 2009 Chairman of the Credentialing Committee, WellStar Cobb Hospital, July 2006 - June 2011 Board of Director, Georgia Society of Clinical Oncology, 2003 - 2008 |
Research Experience | Co-Principal Investigator, NGOC's William S. Gibbons Cancer Research Institute, Current Department of Vascular Biology and Thrombosis, University of Tennessee at Memphis. Elisa for Human Plasma Fibronectin Binding to CD9. Under Dr. Lisa Jennings, Ph.D. June – August 1999. Department of Hematology/Oncology, University of Tennessee at Memphis. Phase I study of combined chemotherapy agents: Etoposide, Topotecan, and Taxotere in solid tumors. Under Dr. Harvey B. Neil. Department of Hematology/Oncology, University of Tenneessee at Memphis. Case report on Plasma Cell Leukemia. Department of Hematology/Oncology, University of Tennessee at Memphis. Case Report on Neurological manifestation of Waldenstrom’s Macroglobulinemia. Department of Hematology/Oncology, University of Tennessee at Memphis. Involved in various CALGB trials. |